Buy & Sell Amphastar Pharmaceuticals Inc (AMPH) – Amphastar Pharmaceuticals Inc Price Today
Aura AI Summary
Key Stats
- $837.77MMarket Cap
- HealthSector
- -36.57%3M Drawdown
- $1.23BEnterprise Value
- -Dividend Yield
- 3 daysTypical Hold Time
Amphastar Pharmaceuticals Inc (AMPH) is currently valued at a market capitalization of $837.77M, with an enterprise value of $1.23B. Over the past 52 weeks, Amphastar Pharmaceuticals Inc has traded between a low of $18.18 and a high of $30.81, highlighting its annual price range. Over the past three months, Amphastar Pharmaceuticals Inc has recorded a drawdown of -36.57%, reflecting recent price volatility. On average, investors hold Amphastar Pharmaceuticals Inc for approximately 3 days, indicating typical investor behavior on the platform.
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Most Recent News
New report details Diageo's financials, SWOT, and market position in Food & Beverages industry
ResearchAndMarkets.com released a comprehensive report on Diageo plc covering its financial performance, SWOT analysis, competitive landscape, and industry position. The report highlights Diageo's strengths like its strong brand portfolio and financi...

Lecanemab injection market to grow to $6.63B by 2030, driven by early Alzheimer's diagnosis and aging population
The global lecanemab injection market is projected to grow from $3.07 billion in 2026 to $6.63 billion by 2030, fueled by increased early-stage Alzheimer's diagnosis, FDA approvals, and expanded reimbursement policies. This growth is supported by inn...

Elon Musk's AI infrastructure shift turns massive losses into $5-6B profit potential
Elon Musk's AI venture xAI, previously incurring heavy losses, is pivoting to become highly profitable by monetizing its AI infrastructure. Instead of just using its Colossus supercomputer for internal AI training, Musk is positioning it as a cloud s...
